| | Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) . . . |
Pending |
10 Dec 2020 |
| | Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) . . . |
Pending |
09 Dec 2020 |
| | Efficacy and Safety of Vitex negundo for MILD COVID-19 Trial (EVICT Program) |
Ongoing |
26 Jan 2021 |
| | Efficacy of a Filipino asthma action plan in the management of children aged 6 to 18 with partly controlled or uncontrolled asthma: A randomized controlled trial . . . |
Completed |
13 Nov 2019 |
| | EffisayilTM 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb dose-finding study to evaluate efficacy and safety of BI 655130 (Spesolimab) compared to placebo in . . . |
Pending |
06 Jan 2021 |
| | Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK8835/PF-04971729) (MK-8835-059) |
Ongoing |
14 Sep 2020 |
| | Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants . . . |
Pending |
23 Jul 2020 |
| | Evaluation of the immunogenicity and safety of Japanese encephalitis vaccine when given with measles-mumps-rubella vaccine . . . |
Completed |
20 Jun 2019 |
| | FALCON Study |
Ongoing |
11 Oct 2019 |
| | Gastrointestinal and genitourinary toxicities in two different dose fractionation regimens of high dose rate intracavitary brachytherapy (7Gy x 4 fractions vs 8Gy x 3 fractions) for carcinoma of the u . . . |
Suspended |
27 Jul 2020 |
| | GenVivo / EPB-002 |
Ongoing |
29 May 2020 |
| | High dose MelAtonin in symptomatic, hypoxemic Covid-19 Patients Requiring hOspitalization (MAC19 PRO): A Randomized, Double-Blind, Placebo Controlled Trial . . . |
Ongoing |
30 Nov -0001 |
| | Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016) . . . |
Ongoing |
10 Dec 2020 |
| | Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) . . . |
Completed |
10 Jul 2020 |
| | Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen |
Completed |
30 Jun 2020 |
| | INVestIgation of rheumatiC AF Treatment Using vitamin K antagonists, rivaroxaban or aspirin Studies (INVICTUS) . . . |
Ongoing |
04 Sep 2019 |
| | IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults |
Terminated |
02 May 2019 |
| | Kailee |
Terminated |
12 May 2017 |
| | Lip Trill Effects on Vocal Function, Vocal Pitch, and Harmonics-to-Noise Ratio: A Multiple Baseline Study of Three Vocally Healthy Females . . . |
Ongoing |
27 Jan 2021 |
| | Long Term Follow-up of Immunogenicity of Healthy Filipino Adults and Children who participated in Phase I study . . . |
Pending |
25 Jun 2019 |
| | Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children with Partial Onset Seizures . . . |
Ongoing |
20 Jun 2019 |
| | Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers . . . |
Completed |
30 Jun 2020 |
| | Long-term Safety & Efficacy Study of Atezolizumab in 2L NSCLC subpopulations |
Ongoing |
11 Mar 2020 |
| | Lupus Study (Extension Study) |
Pending |
16 Dec 2020 |
| | Lupus Study |
Ongoing |
30 Sep 2019 |